000 | a | ||
---|---|---|---|
999 |
_c16145 _d16145 |
||
003 | OSt | ||
005 | 20220201155113.0 | ||
008 | 220201b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_915733 _aKadam, Hari K. |
||
245 | _aUnique synthesis of isochromenoindolone via reductive-oxidative cyclisation approach | ||
250 | _aVol.58(B), Jan. | ||
260 |
_aNew Delhi _bCSIR _c2021 |
||
300 | _a104-108p. | ||
520 | _aFused heterocyclic compounds are extensively studied in medicinal chemistry due to their promising biological properties such as anticancer, antiviral, antimicrobial activities, etc.1-4 Such compounds also find a resemblance to the constituent structures of important natural products5-9 (Figure 1). Indole and isochromane based heterocyclic structures are found in several medicinally important compounds hence a fused convergent structural motif promises interesting biological properties10-13. Isochromenoindolone is one such compound with probable lead to a new class of bioactive compounds14−17. Anticipating a vast potential for medicinal studies for this compound, we directed our efforts towards developing a simple, efficient and versatile method for synthesis of isochromeno[4,3- b]indol-5(11H)-one. | ||
650 | 0 |
_95009 _aGENERAL CHEMISTRY |
|
700 |
_915734 _aTilve, Santosh G. |
||
773 | 0 |
_dNew Delhi NISCAIR-CSIR 2005 _tIndian journal of chemistry (Section B) |
|
856 |
_uhttp://nopr.niscair.res.in/bitstream/123456789/45703/1/IJCB%2058B%281%29%20104-108.pdf _yClick here |
||
942 |
_2ddc _cAR |